Providence Cancer Institute of Oregon is a clinical research site located in Portland, Oregon, United States 97213.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Providence Cancer Institute of Oregon has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer.
Sponsors: HotSpot Therapeutics, Inc, Context Therapeutics Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence Cancer Institute of Oregon has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Cancer Institute of Oregon has 2 clinical trials on record, with 2 currently active. Their work covers Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer.
Providence Cancer Institute of Oregon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.